Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A stock market ticker tape on a desk with a financial newspaper in a dimly lit office.

May 22, 2026

Markets Rally, Oura IPO, Dimon on AI Jobs

U.S. stock markets showed resilience, closing higher despite geopolitical tensions, with notable developments in tech and finance.The Dow Jones Industrial Average achieved a record high, gaining 276 points, or about 0.7%. The NASDAQ Composite and S&P 500 also posted modest increases. This rally occurred against a backdrop of rising tensions with Iran, which has resisted U.S. demands regarding its uranium program. Investors appear to be prioritizing broader economic indicators over immediate geop
Minimalist heart silhouette with circuit pattern

May 22, 2026

What's Driving Cardio Diagnostics Holdings' Recent Stock Surge

Cardio Diagnostics Holdings (CDIO) has recently experienced a significant stock increase of 60.4%, primarily fueled by investor enthusiasm surrounding its innovative AI- and epigenetics-based heart diagnostic technologies.The surge in CDIO's stock, which rose from $3.31 to $5.31 in just days, can be attributed to positive developments in its cardiovascular medicine platform. Investors reacted favorably to updates shared during a recent investor call, where the company highlighted advancements in
A rechargeable battery on a lab bench with a hydrogen fuel cell in the background.

May 22, 2026

Gov't opens new public investment fund for AI, biotech and strategic industries

A new public investment fund has been launched to encourage participation in strategic sectors, including AI and biotechnology, with the aim of generating significant sales.The South Korean government has introduced an investment fund designed to attract public investment, targeting over 600 billion won (approximately $397 million) in sales. This initiative, announced by the Financial Services Commission (FSC), will be accessible for three weeks through various banks and securities firms. The fu
A minimalist representation of an enzyme structure and a molecule in flat design.

May 22, 2026

Biotech firm with ‘Manchester swagger’ wins £5m funding

A biotech startup from the University of Manchester, Imperagen, has successfully secured £5 million in seed funding led by PXN Ventures, aimed at advancing its innovative work in AI and quantum physics for enzyme engineering.This funding round, which also includes contributions from existing investors IQ Capital and Northern Gritstone, brings Imperagen's total funding to £8.5 million. The capital will be utilized to expand research and development, enhance laboratory operations, and grow the AI
Flat illustration of a test tube with a droplet, representing cancer diagnostics.

May 22, 2026

How Investors Are Reacting To Tempus AI (TEM) Expanding Its AI‑Driven Oncology And Alzheimer’s Toolkit

Tempus AI is making significant strides in the life sciences sector, recently securing a $400 million funding round and enhancing its partnerships in oncology and Alzheimer’s research. This includes the launch of the ArteraAI Prostate Test, aimed at improving diagnostics for metastatic hormone-sensitive prostate cancer.The collaboration with Bristol Myers Squibb emphasizes Tempus AI's commitment to integrating its multimodal data and AI capabilities into clinical trials. This partnership is cruc
Flat illustration of an imaging system and plate reader in a laboratory setting.

May 22, 2026

Revvity stock (US76155R1086): diagnostics specialist in focus after latest earnings and life-science

Revvity, a diagnostics and life sciences company, has reported its latest quarterly earnings, emphasizing a strategic shift towards high-growth analytical and genomic solutions. This transition follows its rebranding from PerkinElmer, aiming to solidify its presence in the life sciences sector.Revvity's business model focuses on a combination of one-time instrument sales and recurring revenue from consumables and services. The company offers a diverse range of products, including imaging systems
AI computing hardware in a research lab

May 21, 2026

Kala Pharmaceuticals stock (US4831191000): AI infrastructure pivot draws fresh attention

Kala Pharmaceuticals has recently generated renewed investor interest through a strategic initiative aimed at developing an AI infrastructure platform tailored for the biotech sector, while simultaneously advancing its ophthalmology pipeline.The company plans to establish its own AI computing capabilities, which it intends to share with industry partners. This initiative positions Kala at the intersection of drug development and digital infrastructure, potentially diversifying its revenue stream
A flat design of a clinical trial protocol document with a checkmark

May 21, 2026

Avenio AI Names Dr. Cyrus Ghobadi Board Advisor as Artiko Pharma

Avenio AI has appointed Dr. Cyrus Ghobadi as a Board Advisor, coinciding with Artiko Pharma's adoption of Avenio's Intelligent Protocol Hub to streamline clinical development processes.Dr. Ghobadi, a seasoned expert with extensive experience at major pharmaceutical companies, will leverage Avenio AI's technology to enhance protocol authoring and reduce timelines from IND submission to first-patient-in. His dual perspective as both a physician and a clinical developer positions him uniquely to ad
Minimalist illustration of an oral medication pill on a dark background.

May 21, 2026

What It Takes to Move Machine Learning | PharmExec

The pharmaceutical industry is witnessing a significant shift as lower-priced oral GLP-1 medications from Eli Lilly and Novo Nordisk are attracting patients away from compounded alternatives, while strategic collaborations and insights into AI deployment are shaping the future landscape.Recent reports indicate a notable change in patient preferences, with Eli Lilly's Foundayo and Novo Nordisk's oral Wegovy pills, priced at $149 monthly, becoming more appealing than compounded GLP-1 medications.
Minimalist illustration of an electronic health record with data flow

May 21, 2026

Black Book Research Releases State of Digital Healthcare IT 2026: Denmark Market Report

Black Book Research has unveiled its latest report, "State of Digital Healthcare IT 2026: Denmark," which provides a comprehensive analysis of Denmark's digital health landscape as it transitions towards enhanced healthcare IT optimization.The report delves into various aspects of Denmark's healthcare IT, including electronic health records (EHR) optimization, interoperability, cybersecurity, and the integration of artificial intelligence (AI) within healthcare systems. It emphasizes the country
A tissue sample on a microscope slide in a lab setting

May 21, 2026

Roche to Acquire PathAI to Drive Diagnostics

Roche has announced its intent to acquire PathAI, a leader in digital pathology and AI diagnostics, in a move aimed at enhancing its capabilities in precision medicine.The acquisition, which follows a successful partnership initiated in 2021, will allow Roche to integrate PathAI's advanced digital pathology tools into its existing oncology diagnostic platforms. This integration is expected to streamline diagnostic workflows by transforming traditional manual processes into automated, AI-driven o
A close-up of a pharmaceutical tablet on a pharmacy counter with medication shelves in the background.

May 21, 2026

Aurobindo Pharma Q4 profit inches up 2% as Europe, growth markets offset US drag

Aurobindo Pharma has reported a modest increase in its Q4 profit, attributed to strong performance in European and growth markets despite a decline in US revenues.The company achieved a net profit of Rs. 921 crore for the March quarter, reflecting a 2% rise. Revenue also saw a notable increase, climbing 5.6% to Rs. 8,853 crore. However, the US market presented challenges, with revenues dropping 13% year-over-year to Rs. 3,543 crore.In contrast, Aurobindo's revenues from Europe experienced signif